Syngene International names Peter Bains as MD, CEO
Advertisement
Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an Additional Director, designated him as Managing Director & Chief Executive Officer (a Key Managerial Personnel) of the Company effective April 1, 2025.
In a BSE filing, Syngene stated, "We wish to inform you that the Board of Directors, pursuant to the recommendation of the Nomination and Remuneration Committee (‘NRC’), approved the appointment of Mr. Peter Bains as an Additional Director, designated as Managing Director & Chief Executive Officer (a Key Managerial Personnel) of the Company effective April 1, 2025 subject to the approval of the shareholders of the Company,"
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.